Infectious Disease III: Viral, fungi, and immunocompromised

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/47

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

48 Terms

1
New cards

amphotericin B covers

broad spectrum antifungal;

Yeasts: most candida

molds: aspergillus

2
New cards

conventional amphotericin B doses should not exceed

1.5 mg/kg/day (cardiopulmonary arrest risk)

3
New cards

amphotericin B AE

low K, low MG, nephrotoxic, infusion related reactions

4
New cards

amphotericin B deoxycholate (convention

al formulation) should be pretreated with...

ASA or NSAID

diphenhydramine and/or hydrocortisone

5
New cards

____ is used with amphotericin B to treat invasive cryptococcal (e.g. meningitis) or Candida infections

Flucytosine

6
New cards

Azole antifungals

Fluconazole, voriconazole, posaconazole

7
New cards

Azoles AE

inc LFT, QT prolongation, many drug interactions

8
New cards

Only azole that requires renal dose adjustment

Fluconazole

9
New cards

Azole antifungal which can cause HF

itraconazole

10
New cards

azole antifungal which can cause visual disturbance and phototoxicity

voriconazole

11
New cards

echinocandins

Caspofungin

Micafungin

Anidulafungin

12
New cards

echinocandins MOA

Inhibit cell wall synthesis by inhibiting synthesis of β-glucan.

13
New cards

caspofungin and micafungin warnings

histamine-mediated symptoms (rash, pruritis, facial swelling)

14
New cards

Nystatin administration

-topical powder

-oral (swallow or swish/spit)

15
New cards

terbinafine warnings

hepatotoxicity (avoid in active liver disease)

16
New cards

Candida albicans oropharyngeal infection (oral thrush) preferred treatment

clortrimazole, miconazole

17
New cards

Candida albicans esophageal infection preferred treatment

fluconazole

18
New cards

Candida bloodstream infections preferred treatment

echinocandin

19
New cards

Invasive aspergillus preferred treatment

Voriconazole

20
New cards

cryptococcus meningitis preferred treatment

amphotericin B + flucytosine

21
New cards

dermatophytes (nail bed infection) preferred treatment

terbinafine or itraconazole

22
New cards

Tamiflu should be given within

48 hours of illness onset

23
New cards

Neuraminidase inhibitors

Oseltamivir (Tamiflu), zanamivir, paramivir

24
New cards

Tamiflu decreases the durations of symptoms by

1 day

25
New cards

Tamiflu AE

N/V, neuropsych

26
New cards

HSV1 is most commonly associated wtih

oropharyngeal disease

27
New cards

HSV2 is most commonly associated with

genital disease

28
New cards

Treatment for HSV and varicella zoster virus

Acyclovir, valacyclovir, famiclovir

29
New cards

acyclovir and valacyclovir warnings

caution in renal impairment, geriatrics, concomitant nephrotoxic medications

30
New cards

herpes simplex labialis (cold sores) treatment

docosanol

acyclovir

apply 5 times daily

31
New cards

genital herpes treatment

Acyclovir, valacyclovir

32
New cards

herpes zoster treatment and duration

acyclovir or valacyclovir for 7 days

33
New cards

cytomegalovirus treatment

Ganciclovir

Valganciclovir

34
New cards

Ganciclovir and Valganciclovir boxed warning

myelosuppression

35
New cards

Mono treatment

supportive

36
New cards

A patient on steroids for at least ___ days is considered immunocompromized

14

37
New cards

common opportunistic infections requiring prophylaxis in immunocompromised patients

PJP or PCP

toxoplasmosis gondii encephalitis

mycobacterium avium complex

38
New cards

primary prophylaxis for PJP/PCP

SMX/TMP

alternatives: dapsone, atovaquone, or dapsone + pyrimethamine + leucovorin

39
New cards

criteria for discontinuing PJP/PCP prophylaxis

CD4 count > 200 for >3 months

40
New cards

toxoplasmosis gondii encephalitis prophylaxis

SMX/TMP

alternatives:

atovaquone or dapsone + pyrimethamine + leucovorin

41
New cards

mycobacterium avium complex prophylaxis

azithromycin

42
New cards

mycobacterium avium complex criteria for discontinuing ppx

taking fully suppressive ART

43
New cards

treatment of oral thrush in immunocompromised patient

fluconazole

44
New cards

treatment of cryptococcal meningitis in immunocompromised patient

amphotericin B + flucytosine

45
New cards

treatment of CMV in immunocompromised patient

valganciclovir or ganciclovir

46
New cards

treatment of mycobacterium avium complex in immunocompromised patient

clarithromycin or azithromycin + ethambutol

47
New cards

treatment of PJP in immunocompromised patient

SMX/TMP

48
New cards

treatment of toxoplasmosis gondii in immunocompromised patient

pyrimethamine + leucovorin + sulfadiazine